Cargando…
COVID-19 vaccination in our transplant recipients: The time is now
We are entering 2021 with an expanding and effective COVID-19 vaccine armamentarium. Recent interim results from COVID-19 vaccine trials, including more than 80,000 participants worldwide, demonstrate remarkable efficacy and low rate of serious adverse events. Based on experience with other vaccines...
Autores principales: | Aslam, Saima, Goldstein, Daniel R., Vos, Robin, Gelman, Andrew E., Kittleson, Michelle M., Wolfe, Cameron, Danziger-Isakov, Lara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Heart and Lung Transplantation.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834006/ https://www.ncbi.nlm.nih.gov/pubmed/33487534 http://dx.doi.org/10.1016/j.healun.2020.12.009 |
Ejemplares similares
-
COVID-19 vaccination immune paresis in heart and lung transplantation
por: Aslam, Saima, et al.
Publicado: (2021) -
Impact of COVID-19 in solid organ transplant recipients
por: Danziger-Isakov, Lara, et al.
Publicado: (2021) -
SARS-CoV-2 vaccine boosters: The time to act is now
por: Petersen, Maya, et al.
Publicado: (2021) -
If Not Now, When? Nonserotype Pneumococcal Protein Vaccines
por: McDaniel, Larry S, et al.
Publicado: (2021) -
Healthy indoor air is our fundamental need: the time to act is now
por: Morawska, Lidia, et al.
Publicado: (2022)